Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,226,767 papers from all fields of science
Search
Sign In
Create Free Account
imiglucerase
Known as:
imiglucerase [Chemical/Ingredient]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Narrower (1)
Cerezyme
Drug Allergy
GLUCOSYLCERAMIDASE
Liver diseases
Miglustat
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Case Report: Pancytopenia as an indicator for lysosomal storage disease (Gaucher's Disease)
Alberto Ortega-Rosales
,
Carlos Burneo-Rosales
,
Gilda Romero-Ulloa
,
Gabriela Burneo-Rosales
F1000Research
2019
Corpus ID: 208370008
Introduction: Lysosomal storage disorders are a rare group of diseases with genetic origin in which Gaucher Disease (GD) stands…
Expand
2017
2017
Российский педиатрический опыт по оценке эффективности применения имиглюцеразы для долгосрочной ферментной заместительной терапии болезни Гоше 1-го типа у детей
Г. Б. Мовсисян
,
Лейла Сеймуровна Намазова-баранова
,
+7 authors
Т. М. Букина
2017
Corpus ID: 80469565
Background: Today the gold standard for the treatment of Gaucher’s disease (GD) is an enzyme replacement therapy (ERT) which…
Expand
2015
2015
Experiencia cubana en la terapia de reemplazo enzimático en la Enfermedad de Gaucher
K. L. Sánchez
,
Raquel Fernández Nodarse
,
Pablo Leal Modroña
,
A. G. Otero
,
A. A. Núñez
2015
Corpus ID: 170445464
Normal 0 21 false false false ES-CR X-NONE X-NONE Introduccion : la enfermedad de Gaucher es un desorden hereditario del…
Expand
2011
2011
Effects of a Shortage of Imiglucerase on Three Patients with Type I Gaucher Disease
A. Ferreira
,
S. Sequeira
2011
Corpus ID: 67954714
Gaucher disease (GD) is the most prevalent lysosomal storage disorder (1:50.000) It is caused by an autosomal recessive…
Expand
2011
2011
Monographs: Velaglucerase alfa: a new option for Gaucher disease treatment.
A. Zimran
2011
Corpus ID: 261888073
2009
2009
Beneficios del reemplazo enzimático con imiglucerasa sobre los hallazgos clínicos y de laboratorio en pacientes pediátricos con enfermedad de gaucher no neuronopática
D. Villalobos
,
Hernán D. Valbuena
,
Rosalia Raleigh
,
J. Chacín
2009
Corpus ID: 190581512
Objetivo: Evaluar la respuesta terapeutica alcanzada con la administracion del reemplazo enzimatico con imiglucerasa en pacientes…
Expand
2008
2008
[Enzyme replacement therapy for Gaucher's Disease].
Thomas Winckler
Pharmazie in unserer Zeit
2008
Corpus ID: 196776328
Rekombinant hergestellte Glucocerebrosidase (Imiglucerase, Cerezyme®) zur Therapie der lysosomalen Speicherkrankheit Morbus…
Expand
2008
2008
Choice on termination of pregnancy amendment bill.
J. V. Larsen
South African medical journal = Suid-Afrikaanse…
2008
Corpus ID: 20025418
12 enzyme replacement therapy with imiglucerase (Cerezyme), and at present there are about 30 patients on this programme. An…
Expand
2007
2007
[Diagnosis and treatment of Gaucher disease in Croatia].
M. Mrsić
Liječnički vjesnik
2007
Corpus ID: 45116340
Gaucher disease is the most common lysosomal storage disorder. Incidence of disease is around 1:40-60,000 inhabitants and it is…
Expand
2005
2005
Miglustat: new drug. In type 1 Gaucher's disease : a slight benefit after imiglucerase therapy.
Prescrire international
2005
Corpus ID: 6561508
(1) For patients with type 1 Gaucher's disease the standard treatment is imiglucerase enzyme replacement therapy, provided in…
Expand